ACRUX Ltd (ACR) - Cash Flow Conversion Efficiency
Based on the latest financial reports, ACRUX Ltd (ACR) has a cash flow conversion efficiency ratio of -3.930x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-4.02 Million ≈ $-2.84 Million USD) by net assets (AU$1.02 Million ≈ $723.84K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See ACR equity to assets ratio to measure how much of total assets are equity-financed.
ACRUX Ltd - Cash Flow Conversion Efficiency Trend (2002–2025)
This chart illustrates how ACRUX Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check ACRUX Ltd (ACR) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
ACRUX Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of ACRUX Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Nevada Sunrise Gold Corp
V:NEV
|
-0.157x |
|
Playfair Mining Ltd.
V:PLY
|
0.001x |
|
8I Holdings Ltd
AU:8IH
|
-0.057x |
|
Iterum Therapeutics PLC
NASDAQ:ITRM
|
1.063x |
|
EQTEC plc
LSE:EQT
|
-0.273x |
|
Card Factory PLC
LSE:CARD
|
0.063x |
|
Capstone Holding Corp. Common Stock
NASDAQ:CAPS
|
-0.249x |
|
Inomin Mines Inc
V:MINE
|
-0.133x |
Annual Cash Flow Conversion Efficiency for ACRUX Ltd (2002–2025)
The table below shows the annual cash flow conversion efficiency of ACRUX Ltd from 2002 to 2025. For the full company profile with market capitalisation and key ratios, see ACRUX Ltd stock valuation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | AU$1.02 Million ≈ $723.84K |
AU$-5.47 Million ≈ $-3.87 Million |
-5.348x | -307.16% |
| 2024-06-30 | AU$3.28 Million ≈ $2.32 Million |
AU$-4.30 Million ≈ $-3.04 Million |
-1.313x | -1724.77% |
| 2023-06-30 | AU$8.70 Million ≈ $6.15 Million |
AU$703.00K ≈ $497.42K |
0.081x | +108.33% |
| 2022-06-30 | AU$9.09 Million ≈ $6.43 Million |
AU$-8.82 Million ≈ $-6.24 Million |
-0.970x | -57.00% |
| 2021-06-30 | AU$18.47 Million ≈ $13.07 Million |
AU$-11.41 Million ≈ $-8.08 Million |
-0.618x | +6.95% |
| 2020-06-30 | AU$12.85 Million ≈ $9.09 Million |
AU$-8.53 Million ≈ $-6.04 Million |
-0.664x | -46.59% |
| 2019-06-30 | AU$21.94 Million ≈ $15.52 Million |
AU$-9.94 Million ≈ $-7.03 Million |
-0.453x | -157.07% |
| 2018-06-30 | AU$29.97 Million ≈ $21.21 Million |
AU$-5.28 Million ≈ $-3.74 Million |
-0.176x | -244.00% |
| 2017-06-30 | AU$43.92 Million ≈ $31.08 Million |
AU$5.38 Million ≈ $3.80 Million |
0.122x | -67.46% |
| 2016-06-30 | AU$43.89 Million ≈ $31.05 Million |
AU$16.51 Million ≈ $11.68 Million |
0.376x | +45.25% |
| 2015-06-30 | AU$40.62 Million ≈ $28.74 Million |
AU$10.52 Million ≈ $7.44 Million |
0.259x | -70.06% |
| 2014-06-30 | AU$42.06 Million ≈ $29.76 Million |
AU$36.37 Million ≈ $25.73 Million |
0.865x | +538.23% |
| 2013-06-30 | AU$46.75 Million ≈ $33.08 Million |
AU$6.33 Million ≈ $4.48 Million |
0.135x | +395.86% |
| 2012-06-30 | AU$53.10 Million ≈ $37.57 Million |
AU$-2.43 Million ≈ $-1.72 Million |
-0.046x | -103.22% |
| 2011-06-30 | AU$45.71 Million ≈ $32.34 Million |
AU$65.10 Million ≈ $46.07 Million |
1.424x | +138.17% |
| 2010-06-30 | AU$80.47 Million ≈ $56.94 Million |
AU$48.12 Million ≈ $34.05 Million |
0.598x | +422.97% |
| 2009-06-30 | AU$31.22 Million ≈ $22.09 Million |
AU$-5.78 Million ≈ $-4.09 Million |
-0.185x | -160.08% |
| 2008-06-30 | AU$38.11 Million ≈ $26.96 Million |
AU$-2.71 Million ≈ $-1.92 Million |
-0.071x | +83.13% |
| 2007-06-30 | AU$18.25 Million ≈ $12.91 Million |
AU$-7.70 Million ≈ $-5.45 Million |
-0.422x | -5.57% |
| 2006-06-30 | AU$20.58 Million ≈ $14.56 Million |
AU$-8.23 Million ≈ $-5.82 Million |
-0.400x | -99.63% |
| 2005-06-30 | AU$29.48 Million ≈ $20.86 Million |
AU$-5.90 Million ≈ $-4.18 Million |
-0.200x | +57.55% |
| 2004-06-30 | AU$8.41 Million ≈ $5.95 Million |
AU$-3.97 Million ≈ $-2.81 Million |
-0.472x | -200.45% |
| 2002-06-30 | AU$17.49 Million ≈ $12.37 Million |
AU$-2.74 Million ≈ $-1.94 Million |
-0.157x | -- |
About ACRUX Ltd
Acrux Limited, together with its subsidiaries, develops and commercializes generic and topically applied pharmaceutical products in Australia, Europe, the United States, and internationally. The company provides estradiol transdermal sprays to women for the treatment of flushes associated with menopause under the Evamist and Lenzetto brand names; Dapsone 5% and Dapsone 7.5%, which are gels for th… Read more